ASSETSCurrent assetsCash and equivalentsShort-term investmentsAccounts receivableInventoriesOther current assetsTotal current assetsNet plant, property,and equipmentOther long-term assetsTOTAL ASSETSBattista ProductsBalance Sheet as of December 31, 2014, and December 31, 2013(S in millions)2014$1,651$1,171$ 3,725$ 1,926$ 657$ 9,130$ 9,687$2,2742013$ 1,716$ 3,261$ 3,166 -$1,995Change-$ 65$ 8,681$ 1,693$ 618 $ 39$ 2,107$ 464$ 233$10,454 - $1,324 OWNERS' EQUITYCommon stock$1,006LIABILITIESCurrent liabilitiesAccounts payableShort-term debtOther current liabilitiesTotal current liabilities$167Long-term debtOther long-term liabilitiesTotal liabilitiesRetained earningsTotal owners'equityTOTAL LIABILITIES AND$21,091 $21,242 - $ 151 OWNERS' EQUITY20142013 Change$5,271 $5,357$ 274 $ 2,889$ 1,315 $ 1,160$ 6,860 $ 9,406$ 2,550 $2,313$1,073 $1,688$10,483 $13,407$ 2,614 $2,614$7,994 $5,221$10,608 $7,835-$ 86-$2,615$ 155- $2,546$ 237-$ 615- $2,924$ 0$2,773$2,773$21,091 $21,242 -$ 151 Equity can be thought of as the residual claim on the firm.What is the total equity value of the firm is liabilitiesdecrease to 9564 in 2015, while assets increase to22000 in 2015?

Answered: Equity can be thought of as the…

Equity can be thought of as the residual claim on the firm What is the total equity value of the firm is liabilities decrease to 9564 in 2015, while assets increase to 22000 in 2015?

Cornerstones of Financial Accounting

4th Edition

ISBN:9781337690881

Author:Jay Rich, Jeff Jones

Publisher:Jay Rich, Jeff Jones

Chapter7: Operating Assets

Section: Chapter Questions

Problem 81.3C: Comparative Analysis: Under Armour, Inc., versus Columbia Sportswear Refer to the 10-K reports of...

See similar textbooks

Similar questions

Hcs/380 Calculate the 2022 return on assets ratio
Question One The Purple Lilac has provided the following financial statement as at December 31, 2017 BALANCE SHEET 2016 2017 Non-Current Assets Cost Depn NBV Cost Depn NBV Goodwill 280,000 220,000 Tangible Assets 1,700,000 (330,000) 1,370,000 2,000,000 (410,000) 1,590,000 Long term Investment 230,000 110,000 1,880,000 1,920,000 Current Assets Closing Stock 50,000 35,000 Debtors 35,000 45,000 Short term Investment 40,000 85,000 Bank 0 40,000 Cash 3,500 128,500 11,000 216,000 Total Assets 2,008,500 2,136,000 Capital &…
Investment in Total Net Operating Capital Athenian Venues Inc. just reported the following selected portion of its financial statements for the end of 2020. Your assistant has already calculated the 2020 end-of-year net operating working capital (NOWC) from the full set of financial statements (not shown here), which is $20 million. The total net operating capital for 2019 was $44 million. What was the 2020 net investment in operating capital? Athenian Venues Inc.: Selected Balance Sheet Information as of December 31 (Millions of Dollars) 2020
D CONSOLIDATED STATEMENTS OF FINANCIAL POSITION December 31, December 31, PERCENTAGE 2021 2020 USD USD Assets Current assets Cash and cash equivalents 34,115,412 25,681,845 Short-term financial instruments 71,417,748 80,798,680 Short-term financial assets at amortized cost 2,944,705 2,409,853 Short-term financial assets at fair value through profit or loss 35,624 62,452 Trade receivables 35,585,565 27,065,012 Non-trade receivables 3,930,828 3,150,548 Prepaid expenses 2,042,001 1,980,685 Inventories 36,172,043 28,007,314 Other current assets 4,441,629 3,281,589 Assets held-for-sale - 812,370 Total Current Assets 190,685,555 173,250,348 Non-current assets Financial assets at fair value through other comprehensive income 12,206,843 10,991,369 Financial assets at fair value through profit or loss 1,333,227 1,051,455 Investment in associates and joint ventures…
GIVE THE COMPARATIVE BALANCE SHEET HORIZONTAL ANALYSIS FROM THE GIVEN BALANCE SHEET BELOW JOLLIBEE BALANCE SHEET ASSETS ITEM 2016 2017 2018 2019 2020 Cash & Short Term Investments 17.46B 22.52B 24.17B 23.02B 57.46B Cash & Short Term Investments Growth - 28.99% 7.32% -4.75% 149.59% Cash Only 16.73B 21.11B 23.29B 20.89B 21.36B Short-Term Investments 726M 1.41B 883.2M 2.13B 36.1B Cash & ST Investments / Total Assets 23.96% 25.08% 16.06% 12.28% 27.26% Total Accounts Receivable 3.59B 4.02B 4.86B 5.91B 7.05B Total Accounts Receivable Growth - 11.86% 21.04% 21.46% 19.36% Accounts Receivables, Net 3.03B 3.39B 4.41B 5.37B 5.8B Accounts Receivables, Gross 3.61B 4.08B 5.09B 5.76B 6.46B Bad Debt/Doubtful Accounts (579.79M) (690.12M) (676.91M) (392.36M) (658.63M) Other Receivable 562.75M 630.06M 451.73M 536.62M 1.25B…
GIVE THE COMPARATIVE BALANCE SHEET HORIZONTAL AND VERTICAL ANALYSIS FROM THE GIVEN BALANCE SHEET BELOW JOLLIBEE BALANCE SHEET ASSETS ITEM 2016 2017 2018 2019 2020 Cash & Short Term Investments 17.46B 22.52B 24.17B 23.02B 57.46B Cash & Short Term Investments Growth - 28.99% 7.32% -4.75% 149.59% Cash Only 16.73B 21.11B 23.29B 20.89B 21.36B Short-Term Investments 726M 1.41B 883.2M 2.13B 36.1B Cash & ST Investments / Total Assets 23.96% 25.08% 16.06% 12.28% 27.26% Total Accounts Receivable 3.59B 4.02B 4.86B 5.91B 7.05B Total Accounts Receivable Growth - 11.86% 21.04% 21.46% 19.36% Accounts Receivables, Net 3.03B 3.39B 4.41B 5.37B 5.8B Accounts Receivables, Gross 3.61B 4.08B 5.09B 5.76B 6.46B Bad Debt/Doubtful Accounts (579.79M) (690.12M) (676.91M) (392.36M) (658.63M) Other Receivable 562.75M 630.06M 451.73M…
React Corporation Comparative Statements of Financial Position December 31, 2025 and 2024 2025 2024 Assets Current Assets Cash & Cash Equivalent 106,789 102,375 Trade & Other Receivables 327,611 277,467 Inventory 331,863 297,654 Prepaid Expenses 101,565 114,813 Total Current Assets 870,828 792,309 Noncurrent Assets Property, Plant & Equipment Intangibles 135,754 166,481 Total Noncurrent Assets 7,500 7,500 TOTAL ASSETS 143,254 173,981 1,014,082 966,290 Liabilities and Shareholders’ Equity Current Liabilities Trade & Other Payables Unearned Revenues 238,000 208,703 Notes Payables - current 107,508 82,456 Total Current Liabilities 45,000 45,000…
Current assets: Cash and marketable securities Accounts receivable Inventory Total Assets Fixed assets: Gross plant and equipment Less: Accumulated depreciation Net plant and equipment Other long-term assets Total Total assets Net sales Less: Cost of goods sold Gross profits Less: Other operating expenses 2024 VALIUM'S MEDICAL SUPPLY CORPORATION Balance Sheet as of December 31, 2024 and 2023 (in millions of dollars) $ 72 187 312 $ 571 Earnings per share (EPS) Dividends per share (DPS) Book value per share (BVPS) Market value (price) per share (MVPS) 2023 $ 71 181 291 $ 543 $ 1,073 146 $ 927 134 $ 1,061 $ 1,632 $ 1,446 $ 882 113 $ 769 134 $ 903 Liabilities and Equity Current liabilities: Accrued wages and taxes Accounts payable Notes payable Total Long-term debt Stockholders' equity: Preferred stock (6 thousand shares) Common stock and paid-in surplus (100 thousand shares) Retained earnings Total VALIUM'S MEDICAL SUPPLY CORPORATION Income Statement for Years Ending December 31, 2024 and…
Data needed: SFP Asset section 1. Cash 16.3% 2. AR 6.3% 3. Short term investment 0.2% 4. Inventory 2.2% 5. Prepaid expenses 0.4% 6. PPE 74.7% Data needed: SFP Liabilities and OE section. 1. Current liab 16% 2. Non-current liab 34.2% 3. OE 49.9% Data needed: SCI 1. COGS 38.6% 2. Selling and admin exp 6.8% 3. Interest exp 0.1% 4. Income tax exp 0.5% 5. Net income 54%
GIVE THE COMPARATIVE BALANCE SHEET VERTICAL ANALYSIS FROM THE GIVEN BALANCE SHEET BELOW JOLLIBEE BALANCE SHEET ASSETS ITEM 2016 2017 2018 2019 2020 Cash & Short Term Investments 17.46B 22.52B 24.17B 23.02B 57.46B Cash & Short Term Investments Growth - 28.99% 7.32% -4.75% 149.59% Cash Only 16.73B 21.11B 23.29B 20.89B 21.36B Short-Term Investments 726M 1.41B 883.2M 2.13B 36.1B Cash & ST Investments / Total Assets 23.96% 25.08% 16.06% 12.28% 27.26% Total Accounts Receivable 3.59B 4.02B 4.86B 5.91B 7.05B Total Accounts Receivable Growth - 11.86% 21.04% 21.46% 19.36% Accounts Receivables, Net 3.03B 3.39B 4.41B 5.37B 5.8B Accounts Receivables, Gross 3.61B 4.08B 5.09B 5.76B 6.46B Bad Debt/Doubtful Accounts (579.79M) (690.12M) (676.91M) (392.36M) (658.63M) Other Receivable 562.75M 630.06M 451.73M 536.62M 1.25B…
Consider 2021 consolidated balance sheet and income statement for Pfizer Corporation (PFE). The company projects that its revenue for 2022 will grow at the annual rate of 50%. > All assets are assumed to grow at the same rate as sales. > All current liabilities are assumed to grow at the same rate as sales. All operating expenses are assumed to grow at the same annual growth rate as sales. All non-operating income/expenses as well as depreciation and amortization are assumed to remain at the same level as they were in 2021. For the time being, the company wants to keep its long-term debt at 2021 level. Company plans to keep the same dividend payout ratio as it did in 2021. Balance Sheet as of December 31, 2021 Assets Liabilities and Owner's Equity Current Assets Current Liabilities Cash & Short Term 31,069 Current Portion of Long Term Debt 1,636 Investments 11,479 Accounts Payable 9,059 | Income Tax Payable 8,086 Other Current Liabilities Dividends Payable Accrued Payroll Notes Payable…
Cash Flow Asset End of year Amount Appropriate Required Return D 1 through 5 $1,500 12% 6 $8,500 By using cell references to the given datea and the function PV, Calculate the value of asset D.